Sarepta Therapeutics
SRPTSarepta Therapeutics, Inc. (NASDAQ: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Sarepta Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/12/2025 | Sell | Nicaise, Claude | Director | $99.6 | $248,203 |
| 12/12/2024 | Sell | Wigzell, Hans Lennart Rudolf | Director | $124.8 | $1,310,820 |
| 12/5/2024 | Sell | Boor, Kathryn Jean | Director | $125.6 | $205,400 |
| 8/30/2024 | Sell | Estepan, Ian Michael | Chief Financial Officer | $137.4 | $822,100 |
| 8/16/2024 | Buy | Chambers, Michael Andrew | Director | $133.9 | $4,955,728 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)